Unichem Labs bags USFDA nod for Zonisamide Capsules
Mumbai: Drug maker, Unichem Laboratories Limited, has recently announced that the company has received Abbreviated New Drug Application (ANDA) approval for its Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA).
The product is a generic version of Zonegran (Zonisamide) Capsules of Sunovion Pharmaceuticals Inc.
Zonisamide Capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.
The product will be commercialized from Unichem's Goa Plant.
Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company.
It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
